We found that mobilizing T2 transposons with GFAP-SB11 on an otherwise wild-type background did not promote gliomas, and very rare gliomas were observed when transposons were mobilized on a p19Arf+/− cancer predisposed background. The gene discussed is GFAP; the disease is glioma.